平阳霉素局部注射治疗口腔颌面颈部淋巴管瘤

目的:探讨平阳霉素治疗口腔颌面颈部淋巴管瘤的疗效和适应症。方法:195例口腔颌面颈部淋巴管瘤患者的200个瘤体采用平阳霉素瘤内局部注射治疗。毛细管型和海绵型淋巴管瘤在瘤体内作分点注射;囊肿型淋巴管瘤则抽出部分囊液后,再注射药液。治疗周期及用药量根据淋巴管瘤的部位、大小、类型和患者年龄而定。评价其治疗效果。结果:总有效率为5415%(109/200),其中囊肿型淋巴管瘤疗效最好,有效率为100%(51/51),而海绵型和毛细管型及其混合型的有效率分别为46136%(51/110),16166%(3/18),19105%(4/21)。结论:平阳霉素局部注射疗法可作为口腔颌面颈部淋巴管瘤,尤其是囊肿型淋巴管瘤的首选治疗方法。

A Study of Effects of Pingyangmycin Injection on Treatment of Lymphangiomas in Oral, Maxillofacial and Cervical Regions

OBJECTIVE: The purpose of this study was to investigate the indication and therapeutic effects of Pingyangmycin injection as a primary therapy of lymphangiomas in oral, maxillofacial and cervical region. METHODS: A total of 195 patients (106 males and 89 females) with lymphangiomas in oral and maxillofacial regions were treated in the affiliated dental hospital of Sichuan University from May 1990 to December 2000. The patients' ages ranged from 0.5 to 46 years. The tongue was the most commonly involved site, followed by the cheek and the neck. The 200 lymphangiomas (5 patients had 2 lymphangiomas in different sites) underwent the therapy of Pingyangmycin, which was injected as with 1 mg/ml in saline. The total dose of Pingyangmycin ranged from 5 mg to 70 mg and 5 to 58 times, 1 time per 2-4 weeks. RESULTS: The curative rate of cystic-type lymphangiomas was the highest. Of the 51 cystic lymphangiomas, 110 capillary lymphangiomas, 18 cavernous lymphangiomas and 21 combinations of capillary and cavenous lymphangiomas, the curative rates were respectively 100% (51), 46.36% (51), 16.16% (3) and 19.05% (4), which showed a significant therapeutic effect, respectively. And 40(78.43%), 19(17.27%), 2(11.11%) and 0(0%) of them completely disappeared. There was no serious side effect with Pingyangmycin-injection treatment, such as pulmonary fibrosis. CONCLUSION: The treatment of injection of Pingyangmycin is a selective primary method of lymphangiomas, which can reduce the size of lymphangiomas, and make them completely disappeared.